Romain Fournier

Chief Editor
Having worked in the British, French and Swiss financial press, Romain is able to report on local and international issues, as comfortable in French as in the language of Shakespeare, Romain Fournier leads the editorial team at Marketscreener. Fine connoisseur of the English-speaking markets, Romain delivers an editorial every day on US and UK markets.

Global markets live: Honda, Shopify, Meta, ASOS, Gilead Sciences...

04/12/2022 | 12:10pm EDT

Every day, the MarketScreener team selects the most important information about listed companies around the world.




  • The Benetton family, together with Blackstone, is reportedly close to a takeover bid for Atlantia.
  • Sika sales jump 22% to CHF 2.4bn in Q1, boosted by volumes and price increases.
  • Nokia will stop doing business in Russia.
  • Givaudan reports Q1 sales growth of 4.6%.
  • Honda will invest $64B in R&D over time to strengthen in electric.
  • Shopify launches a ten-for-one stock split.
  • Meta Platforms tests virtual item sales in the metaverse.
  • Bone Therapeutics signs dilutive convertible bond agreement with Alpha Blue Ocean.
  • BB Biotech completes its share repurchase program.
  • ASOS first-half profit drops 87% due to supply chain constraints.
  • Lalique signs a new licensing agreement to create and market fragrances for Superdry.
  • The European Commission has given the green light to Parker-Hannifin's proposed acquisition of the British company Meggitt for £6.3 billion.
  • American Airlines announced Tuesday that it expects revenue to fall 16% in the first three months of the year compared to the first quarter of 2019, which was before the COVID-19 pandemic, as the sector suffered from a lack of headcount in particular.
  • Gilead Sciences - The Food and Drug Administration (FDA) on Monday night lifted an order to halt clinical trials of a treatment for certain forms of blood cancer developed by the company, which was issued in January to review safety data from those trials. Piper Sandler raised its price target after the decision to $72 from $71.
  • Myovant and Pfizer - The U.S. drug agency informed the two U.S. companies that their application to extend the use of Myfembree for endometriosis pain was deficient. 

Main earnings releases: LVMH, Sika, Givaudan, Albertsons, JD Sports, Evotec, Pennon, ASOS ... 

© 2022
Stocks mentioned in the article
ChangeLast1st jan.
ALBERTSONS COMPANIES, INC. -2.91% 28.07 Delayed Quote.-7.02%
AMERICAN AIRLINES GROUP INC. 1.73% 15.25 Delayed Quote.-15.09%
ASOS PLC -1.94% 987.5 Delayed Quote.-58.70%
ATLANTIA SPA 0.22% 22.8 Delayed Quote.30.62%
BB BIOTECH AG -0.95% 62.3 Delayed Quote.-19.25%
BLACKSTONE INC. 2.62% 108.79 Delayed Quote.-15.92%
BONE THERAPEUTICS SA -5.52% 0.274 Real-time Quote.-58.86%
EVOTEC SE 6.20% 26.88 Delayed Quote.-36.75%
GILEAD SCIENCES, INC. 0.82% 62.96 Delayed Quote.-13.29%
GIVAUDAN SA 0.27% 3368 Delayed Quote.-29.72%
HONDA MOTOR CO., LTD. 3.82% 3557 Delayed Quote.10.12%
JD SPORTS FASHION PLC -1.86% 129.1 Delayed Quote.-40.73%
LALIQUE GROUP SA 2.27% 36 Delayed Quote.-9.09%
LVMH MOËT HENNESSY LOUIS VUITTON SE 0.13% 694.5 Real-time Quote.-4.47%
MEGGITT PLC -0.13% 792 Delayed Quote.7.32%
META PLATFORMS, INC. 1.70% 180.5 Delayed Quote.-46.34%
MYOVANT SCIENCES LTD. 4.46% 18.49 Delayed Quote.18.75%
NOKIA OYJ -0.20% 5.06 Delayed Quote.-9.22%
PARKER-HANNIFIN CORPORATION 1.90% 308 Delayed Quote.-3.18%
PENNON GROUP PLC -0.29% 1022 Delayed Quote.-12.43%
PFIZER, INC. 3.77% 50.11 Delayed Quote.-15.14%
SHOPIFY INC. 0.84% 40.76 Delayed Quote.-70.41%
SIKA AG -1.18% 243.4 Delayed Quote.-35.98%
SUPERDRY PLC -0.58% 136.6 Delayed Quote.-50.77%